Cargando…

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers

Detalles Bibliográficos
Autores principales:	Piperidou, Alexia, Zografos, Eleftherios, Vassilakopoulos, Theodoros P., Angelopoulou, Maria K., Hlias, Georgios, Pappis, Vassiliki, Boutsikas, George, Dimou, Maria, Petevi, Kyriaki, Kanellopoulos, Alexandros, Kyrtsonis, Marie-Christine, Panayiotidis, Panayiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Genomics, Biology & Microenvironment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621544/ http://dx.doi.org/10.1097/01.HS9.0000890772.42494.4b

Ejemplares similares

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients
por: Angelopoulou, Maria K., et al.
Publicado: (2014)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
por: Karatrasoglou, Eleni A., et al.
Publicado: (2023)

Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2023)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2010)

New Insights into Monoclonal B-Cell Lymphocytosis
por: Kalpadakis, Christina, et al.
Publicado: (2014)

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study
por: Anargyrou, Konstantinos, et al.
Publicado: (2019)

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2020)

Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
por: Terpos, Evangelos, et al.
Publicado: (2021)

Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, (Tyr)p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance
por: Levidou, Georgia, et al.
Publicado: (2014)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
por: Kakkas, Ioannis, et al.
Publicado: (2021)

Poor Neutralizing Antibody Responses in Patients with CLL, NHL and HL after Vaccination Against Sars-Cov-2; A Prospective Study in 132 Patients
por: Terpos, Evangelos, et al.
Publicado: (2021)

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
por: Koulieris, Efstathios, et al.
Publicado: (2012)

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2014)

Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma
por: Piperidou, Alexia, et al.
Publicado: (2022)

Can resistive breathing injure the lung? Implications for COPD exacerbations
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2016)

New Insights into Malignant B-Cell Disorders
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2015)

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
por: Angelopoulou, M K, et al.
Publicado: (2016)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2019)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

(PO-051) Catatonic with COVID-19
por: Patel, Prit, et al.
Publicado: (2022)

Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease “sanctuary” during venetoclax treatment?
por: Dimou, Maria, et al.
Publicado: (2021)

Bench-to-bedside review: Weaning failure – should we rest the respiratory muscles with controlled mechanical ventilation?
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2006)

What’s new about pulmonary hyperinflation in mechanically ventilated critical patients
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2020)

Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma
por: Chatzidimitriou, Chrysovalantou, et al.
Publicado: (2021)

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction
por: Toumpanakis, Dimitrios, et al.
Publicado: (2017)

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2016)

Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats
por: Clarke, Julie M., et al.
Publicado: (2012)

Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice
por: Akinsete, Juliana A., et al.
Publicado: (2012)

Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
por: Oji, Yusuke, et al.
Publicado: (2016)

Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis
por: Inoue-Yamauchi, Akane, et al.
Publicado: (2018)

Inhibition of Nox4‐dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal‐mediated protumorigenic interactions
por: Sampson, Natalie, et al.
Publicado: (2018)

The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
por: Berntsson, Jonna, et al.
Publicado: (2017)

Hyperactive gp130/STAT3‐driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development
por: Hill, David G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_itgvfkgvei2e3p6kst0p066f0f